SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

60 DEGREES PHARMACEUTICALS, INC. (SXTP)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence
Probe Score
2.5 / 10
Letters
1
Latest Activity
Jul. 10, 2025
Version
v1

Score Breakdown

Letter Count
1.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Jul. 10, 2025 CORRESP Neutral/Informational High The correspondence from H.C. Wainwright & Co., LLC, acting as the placement agent for 60 Degrees Pharmaceuticals, Inc., requests the SEC to expedite the effectiveness of the Regis… Read Filing EDGAR
Jul. 10, 2025 CORRESP Neutral/Informational Moderate 60 Degrees Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, aiming for it to be eff… Read Filing EDGAR
Jun. 13, 2025 UPLOAD Neutral/Informational Low The SEC correspondence dated June 13, 2025, informs Geoffrey S. Dow, the CEO of 60 Degrees Pharmaceuticals, Inc., that the SEC does not intend to review the company's draft regist… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.